Medication Management in Early Psychosis and At-risk States

This live presentation will take place on September 24th, 2020

10:00-11:15amPST/1:00-2:15pmEST

Register in advance for this webinar:

https://stanford.zoom.us/webinar/register/WN_AYqHtnUbR9-vl9W04UMKMg

After registering, you will receive a confirmation email containing information about joining the webinar.

Overview

This webinar will focus on approaches to psychopharmacology for people at clinical high risk for psychosis or who are early in the course of a psychotic illness. We will discuss when it is appropriate to start antipsychotic medication and how to work with patients/families around the starting of medication. We will have a discussion of evidence-based medications for psychosis, including clozapine, and other adjunctive medications to consider in addition to antipsychotics. We will also have a discussion of the newest antipsychotics on the market and how to consider their use in this population.

Attendees will have an opportunity to participate in Q&A.

Pricing

FREE - $0

Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Learning Objectives

1. Identify key differences in use of medications in first-episode psychosis (FEP) vs. clinical high risk (CHR).

2. Describe three tools for working with families and consumers on understanding the role of medication in treatment.

3. Summarize current evidence-based medications for psychosis and new medications available in the market.

 

Target Audience

Nurse/Nurse Practitioner, Pharmacist, Psychiatrist, Physician (Non-psychiatrist), Physician Assistant

Instructional Level

Introductory, Intermediate

Estimated Time to Complete

Estimated Duration: 1.25 hour
Program Start Date: September 24, 2020 
Program End Date: September 24, 2020

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by attending the live presentation and completing the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (other professions) showing the event date and hours earned.

Continuing Education Credit

Physicians

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this live event for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Faculty and Planner Disclosures

Instructor

Jacob S. Ballon, M.D., M.P.H.

Dr. Ballon specializes in the treatment of people with psychotic disorders including schizophrenia. He is the Co-Director of the INSPIRE Clinic at Stanford which provides interdisciplinary care for people experiencing psychosis. He is also the medical director of H2 acute inpatient unit and the co-director of the specialty psychiatry clinics section in the Department of Psychiatry. Dr. Ballon completed his residency at Stanford in 2009 and a Schizophrenia Research Fellowship at Columbia University in 2011.

Disclosure – Consultant: Alto Pharmacy, Corcept

Planners

· Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests. 

·  Amy N. Cohen, PhD, American Psychiatric Association. Reports no financial relationships with commercial interests.

· Tristan Gorrindo, MD, American Psychiatric Association. Reports no financial relationships with commercial interests.

· Judith Dauberman, PhD, Stanford University. Reports no financial relationships with commercial interests.

 

Accessibility for Participants with Disabilities

PEPPNET is committed to ensuring accessibility of its website to people with disabilities.  Please contact PEPPNET at 650)723-2963 if you require assistance seven (7) days prior to the start of a live webinar.

For assistance: Contact jdauberm@stanford.edu for questions about this course and for technical assistance.

Hardware/Software Requirements

Supported operating systems

·         macOS X with macOS 10.7 or later

·         Windows 10

·         Windows 8 or 8.1

·         Windows 7

·         Windows Vista with SP1 or later

·         Windows XP with SP3 or later

·         Ubuntu 12.04 or higher

·         Mint 17.1 or higher

·         Red Hat Enterprise Linux 6.4 or higher

·         Oracle Linux 6.4 or higher

·         CentOS 6.4 or higher

·         Fedora 21 or higher

·         OpenSUSE 13.2 or higher

·         ArchLinux (64-bit only)

Supported tablet and mobile devices

·         Surface PRO 2 running Win 8.1

·         Surface PRO 3 running Win 10

·         iOS and Android devices

·         Blackberry devices

Supported browsers

·         Windows: IE 11+,  Edge 12+, Firefox 27+,  Chrome 30+

·         Mac: Safari 7+, Firefox 27+,  Chrome 30+

·         Linux: Firefox 27+,  Chrome 30+